Skip to main content
Bafna Pharmaceuticals Limited logo

Bafna Pharmaceuticals Limited — Investor Relations & Filings

Ticker · BAFNAPH ISIN · INE878I01022 LEI · 984500D03E2C7Y5EE587 BSE.NS Manufacturing
Open in API
Filings indexed 247 across all filing types
Latest filing 2024-06-29 Regulatory Filings
Country IN India
Listing BSE.NS BAFNAPH

About Bafna Pharmaceuticals Limited

http://bafnapharma.com/

Bafna Pharmaceuticals Limited specializes in the development, manufacture, and marketing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities certified by WHO-GMP standards, ensuring high-quality production of finished dosage forms including tablets, capsules, syrups, and suspensions. Its therapeutic portfolio spans multiple categories such as anti-infectives, analgesics, cardiovascular, gastrointestinal, and vitamins. The organization serves both domestic and international markets, with a significant presence in emerging regions across Africa, Southeast Asia, and the CIS. In addition to its proprietary product line, the company provides comprehensive contract manufacturing and formulation development services, leveraging its technical expertise and regulatory compliance to meet global healthcare requirements.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about a temporary disruption of operations at a manufacturing facility. It is addressed to stock exchanges and provides operational update information rather than financial data or detailed reports. The document is short (2407 characters) and serves as a regulatory announcement about an operational event. It does not contain financial statements, audit information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-06-29 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter from Bafna Pharmaceuticals Limited addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the announcement of the company's unaudited financial results for the quarter ending June 30, 2024. It references regulatory compliance with SEBI insider trading regulations and specifies the trading window closure period. The document does not contain any financial statements, detailed financial data, or the actual financial results. It is an announcement related to trading restrictions prior to a financial report, not the report itself. The document length is short (2035 characters), and it serves as a regulatory announcement rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2024-06-25 English
Copy of Newspaper Publication
Regulatory Filings
2024-05-31 English
Change in Company Secretary/Compliance Officer
Board/Management Information Classification · 100% confidence The document is an official communication from Bafna Pharmaceuticals Limited to stock exchanges regarding the appointment of a new Company Secretary & Compliance Officer. It references Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure of material events including changes in key managerial personnel. The content includes details about the appointment, the date, and the profile of the appointee. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement of a change in senior management rather than a full management report or annual report. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3613 characters, which is consistent with a detailed announcement but not a full report.
2024-05-29 English
Outcome of Board Meeting
Regulatory Filings
2024-05-29 English
Financial Result Updates
Regulatory Filings
2024-05-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.